Enteric Parasitic Infections

1. Anon.  Drugs for parasitic infections.  Treatment Guidelines Med Lett 2013;:e1-31.
2. Bruckner DA.  Amebiasis.  Clin Microbiol Rev 1992;5:356-69.
3. Cabada MM, White AC.  Treatment of cryptosporidiosis:  do we know what we think we know?  Curr Opin Infect Dis 2010;23:494-9.
4. Chen TL, Chan CC, Chen HP, et al.  Clinical characteristics and endoscopic findings associated with Blastocystis hominis in healthy adults.  Am J Trop Med Hyg 2003;69:213-6.
5. Cook GC.  Use of benzimidazole chemotherapy in human helminthiases: indications and efficacy.  Parasitology Today 1990;6:133-6.
6. Coyle CM, Varughese J, Weiss LM, et al.  Blastocystis:  To treat or not to treat….Clin Infect Dis 2012;54:105-10.
7. Craig P, Ito A.  Intestinal cestodes.  Curr Opin Infect Dis 2007;20:524-32.
8. Gilbert DN, Moellering RC, Eliopoulos GM, eds.  The Sanford guide to antimicrobial therapy 2012. Sperryville, VA:  Antimicrobial Therapy, Inc. 2012.
9. Graham CS, Brodie SB, Weller PF.  Imported Fasciola hepatica infection in the United States and treatment with triclabendazole.  Clin Infect Dis 2001;33:1-5.
10. Hamblin J, Connor PD.  Pinworms in pregnancy.  IABFP 1995;8:321-4.
11. Haresh K, Suresh K, Khairil Anus A, et al.  Isolate resistance of Blastocystis hominis to metronidazole.  Trop Med Int Health 1999;4:274-7.
12. Khaw M, Panosian CB.  Human antiprotozoal therapy: past, present and future.  Clin Microbiol Rev 1995;8:427-39.
13. Keiser J, Utzinger J.  Efficacy of current drugs against soil-transmitted helminth infections.  JAMA 2008;299:1937-48.
14. Koutsavlis AT, Valiquette L, Allard R, et al.  Blastocystis hominis:  a new pathogen in daycare centres?  CCDR 2001:27:1-7.
15. Liu LX, Weller PF.  Antiparasitic drugs.  N Engl J Med 1996;334:1178-84.
16. Mandell GL, Bennett JE, and Dolin R, eds.  Mandell, Douglas and Bennett’s principles & practice of infectious diseases. 7th ed. New York: Churchill Livingstone Inc. 2009.
17. Marshall MM, Naumovitz D, Ortega Y, et al.  Waterborne protozoan pathogens.  Clin Microbiol Rev 1997;10:67-85.
18. Montes M, Sawhney C, Barros N.  Strongyloides stercoralis:  there but not seen.  Curr Opin Infect Dis 2010;23:500-4.
19. Nash TE, Ohl CA, Thomas E, et al.  Treatment of patients with refractory giardiasis.  Clin Infect Dis 2001;33:22-8.
20. Nigro L, Larocca L, Massarelli L, et al.  A placebo-controlled treatment trial of Blastocystis hominis infection with metronidazole.  J Travel Med 2003;10:128-30.
21. Ok UZ, Girginkardesler N, Balcioglu C, et al.  Effect of trimethoprim-sulfamethoxazole in Blastocystis hominis infection.  Am J Gastroenterol 1999;94:3245-7.
22. Okhuysen PC.  Traveler’s diarrhea due to intestinal protozoa.  Clin Infect Dis 2001;33:110-4.
23. Ortega YR, Adam RD.  Giardia:  overview and update.  Clin Infect Dis 1997;25:545-50.
24. Ravdin JI.  Amebiasis.  Clin Infect Dis 1995;20:1453-66.
25. Rosenblatt JE.  Antiparasitic agents.  Mayo Clin Proc 1992;67:276-87.
26. Segarra-Newnham M.  Manifestations, diagnosis, and treatment of Strongyloides stercoralis infection.  Ann Pharmacother 2007;41:1992-2001.
27. Smith JW.  Strongyloidiasis.  Clin Microbiol Newslet 1991;13:33-7.
28. Stark D, Barratt JLN, van Hal S, et al.  Clinical significance of enteric protozoa in the immunosuppressed human population.  Clin Microbiol Rev 2009;22:634-50.
29. Stenzel DJ, Boreham PFL.  Blastocystis hominis revisited.  Clin Microbiol Rev 1996;9:563-84.
30. Tan KSW.  New insights on classification, identification, and clinical relevance of Blastocystis spp.  Clin Microbiol Rev 2008;21:639-65.
31. Wang KX, Li CP, Wang J, et al.  Epidemiological survey of Blastocystis hominis in Huainan city, Anhui province, China.  World J Gastroenterol 2002;8:928-32.
32. Wolfe MS.  Giardiasis.  Clin Microbiol Rev 1992;5:93-100.
33. Yereli K, Balcioglu IC, Ertan P, et al.  Albendazole as an alternative therapeutic agent for childhood giardiasis in Turkey.  Clin Micro Infect 2004;10:527-9.
34. Zierdt CH.  Blastocystis hominis - past and future.  Clin Microbiol Rev 1991;4:61-79.